your on and of joining Thank Pharma. each the of our experienced I of policy you We’ve to in promote Diana, continued the from total sales government the support morning, presence expenditures good of to everyone. on thank of through vigorously the for China its offers proportion patients’ sales the China solicit in markets. impacts tender implementation strict for you, and endeavors today us Pharma market recent expand openings controlling negative Management active hospitals. to drugs participation and spending new drug in these allow to provincial
stringent our are standards, requirements we challenging consistency this registration environment addition, period. and In experiencing of pressure the more the from evaluations drug in sustained industry in
will conditions the the we products, We in the actively will Simultaneously, guidance our optimize further pipeline continue our market, actively nutrition to launch existing development adapting evaluating and strategy. products, market our of and for policy order to competition state in implement products. current also
will I English. remarks prepared Li’s now Ms. in read of the rest
million for in Now months I our second $X.X compared XX, to of the the ended to reaction spending the months percentage XXXX. to would medicines Revenue XX, the the balance market by June XXXX, mainly and $X.X for million XX% results patients’ information. quarter caused sheet on XXXX financial three was like ended three to June the decreased as review of to on policy due decrease total This controlling by implementation of strict expenditure the hospitals.
to period XX, same during June XXXX ended $X.X as the in $X.X months three the for compared XXXX. million was million, profit Gross
ratio and fixed during as decrease XXXX. in decrease the margin of June period Our due three in to cost our was XXXX the The in the was revenue. XX.X% same gross increased the the mainly gross profit compared profit XX, months revenue ended in margin to X.X% to
Because accounted expenses of million $X.X three expenses revenue XXXX, the in XXXX respectively. XX, XX.X% for compared and of months of we accounts and period our were June the our expenses our to Selling XX, to ended and policies, personnel in and XXXX sales receivables. the months practices, as number the the three XX.X% same the adjustments June efficiently during selling and for $X.X in XXXX. support of total ended the Our the collection sales reduced reform of million healthcare
and Our General were for our million in XX.X% administrative XX, as months revenues and in the total expenses for months XXXX, ended three XXXX administrative period ended million, to June general and expenses for same respectively. XXXX XXXX. $X.X June three the the accounted $X.X compared XX.X% XX, and of
ended same revenues the XX, X.X% period June accounted and expenses as months and this to current existing XXXX increase of ended XXXX, respectively. $X.XX development research million the products. three three evaluation XXXX. our in spending on consistency to and for total in in the XX, and mainly The June was in the period of Our million, development Research $X.XX XXXX for X.X% compared our were expenses and expenses months the research in development due
Our ended compared debt bad June as the period XXXX. XXXX – for were in $XX,XXX, the – for months XX, same expenses $XXX,XXX three to
in months June $X.XX diluted as compared decrease basic impact for mainly share, per on expenditures and common was loss Net of period common the $X.X to revenue. was diluted result in ago, million and share. of controls loss a the decrease a the net XXXX three year or basic loss XX, per same of ended for the outweighed net or $X.XX $X.X million, The
XX.X% spending on to to on percentage ended months six to of controlling compared for mainly decrease results, the million XX, the as June months XXXX. was in implementation million recent for six quarters. by hospital expenditure due policies medicine $X.X months the government ended total June the $X.X decreased of revenue XXXX, This XX, Six
June XX, was for in in XXXX million the compared million, same months ended profit $X.X six XXXX. Gross to $X.X period the
to the in decrease due the XX.X% mainly sales Our was in same XX.X% profit XX, to months in gross the margin six of decrease June in half ended period margin XXXX. gross XXXX. in was in profit compared the XXXX The our first
as nature cost the stable in of margin in decreased deteriorates fixed revenue of the the that cost. cost gross outweighed when well, decrease this Although period
XXXX June million, This ended XXXX and expenditure to the six June XX, XX, revenue $X.XX decreased months Net XXXX. ended in reflected share. loss $X.X decreased basic and for the six the offset common diluted of per both was months or
balance of the of sheet, XXXX, XXXX. had to June compared XX, equivalents Turning December as cash $X.X million the as Company XX, $X.X of million and cash to the
accounts as was As XXXX, December million million of compared $X.X XX, to net June receivable XXXX. of XX, our $X.X
to For the in period XXXX, operating from for million months cash as XX, June same activities six million $X.X flow compared $X.X the ended was XXXX.
call believe and to fair the sales shareholders' now With on will and the focusing of support questions. we up future. development that that Overall, this promote will our open continue business valuation our Operator? will in our we the interest
